Arrowhead Research reported $32.74M in Selling and Administration Expenses for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Agios Pharmaceuticals AGIO:US $ 28.26M 3.25M
Alnylam Pharmaceuticals ALNY:US $ 169.98M 15.51M
Anika Therapeutics ANIK:US $ 21.27M 2.07M
Arrowhead Research ARWR:US $ 32.74M 1.12M
Bluebird Bio BLUE:US $ 36.69M 588K
Cerulean Pharma CERU:US $ 2.59M 168.34K
Heron Therapeutics HRTX:US $ 32.12M 836K
Intercept Pharmaceuticals ICPT:US $ 39.98M 10.02M
IONIS PHARMACEUT IONS:US $ 33.8M 325K
Ligand Pharmaceuticals LGND:US $ 29.17M 10.99M
Merk MRK:US $ 2.42B 118M
Mirati Therapeutics MRTX:US $ 54.23M 277K
Moderna Inc MRNA:US 211M 57M
Nektar Therapeutics NKTR:US $ 21.44M 5.9M
Novartis NOVN:VX 3.59B 91M
Opko Health OPK:US $ 101.46M 16.07M
Sarepta Therapeutics SRPT:US $ 154.32M 82.48M
Spectrum Pharmaceuticals SPPI:US $ 9.38M 485K
Tg Therapeutics TGTX:US $ 12.64M 7.97M
Ultragenyx Pharmaceutical RARE:US $ 68.14M 825K
Vertex Pharmaceuticals VRTX:US $ 215.3M 100K
Xencor XNCR:US $ 11.09M 182K
YTE INCY:US $ 253.28M 43.69M